NextCure Inc – Quartalsfinanzdaten (NASDAQ:NXTC) | MetaTrader

Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik

Vierteljährlich Jährlich

Mittelzufluss aus laufender Geschäftstätigkeit -6.97 M-12.99 M-22.71 M-6.27 M-7.64 M -49.61 M Mittelzufluss aus Investitionstätigkeit 6.96 M7.09 M3.76 M8.7 M6 M 25.56 M Zahlungsströme aus der Finanzierungstätigkeit 37 K1 000106 K020.29 M — Freier Cashflow -6.93 M-12.99 M-22.71 M-6.27 M-7.64 M -49.61 M

Nachrichten

NextCure gibt Update zu ADC-Programmen und meldet Liquiditätsbestand

NextCure provides updates on ADC programs, reports cash position

NextCure secures $21.5 million in private placement to extend cash runway

NextCure raises $21.5 million in private placement to fund ADC programs

Does NextCure (NXTC) Have the Potential to Rally 107.88% as Wall Street Analysts Expect?

Curanex Pharmaceuticals closes $15 million IPO on NASDAQ

NextCure (NXTC) Q2 Loss Widens 71%

NextCure stock soars after positive data for bone disease treatment

Why Deckers Outdoor Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - Absci (NASDAQ:ABSI), AST SpaceMobile (NASDAQ:ASTS)

Piper Sandler lowers NextCure stock price target to $15 after reverse split

NextCure initiates one-for-twelve reverse stock split on Nasdaq

Upcoming Stock Splits This Week (July 14 to July 18) – Stay Invested - TipRanks.com